Wikidata

(Q61907055)

English

Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin

clinical trial

In more languages

Statements

title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Asian Subjects With T2DM and Inadequate Glycemic Control on Metformin and Saxagliptin (DS Navigation) (English)
0 references
sponsor
AstraZeneca
0 references
country
Thailand
0 references
Vietnam
0 references
start time
28 February 2019
0 references
end time
1 March 2021
0 references
number of participants
342
0 references
research intervention
saxagliptin
0 references
metformin
0 references
minimum age
18 year
0 references
maximum age
130 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61907055&oldid=2149042088"